There is growing interest in discrete-choice experiments (DCE) as a method to elicit consumers' preferences in the health care sector. Increasingly this method is used to determine willingness-to-pay (WTP) for health-related goods. However, its external validity in the health care domain has not been investigated until today. This paper examines the external validity of DCE concerning the reduction of a health risk. Convergent validity is examined by comparing the value of a statistical life with other preference elicitation techniques, such as revealed preference. Criterion validity is shown by comparing WTP values derived from stated choices in the experiment with those derived from actual choices made by the same individuals. Both tests provide strong evidence in favor of external validity of the DCE method. JEL Classification Numbers: C25, C52, D12, I18, I19
Introduction
Discrete-choice experiments (DCE) are designed to allow individuals to express their preferences for non-marketed goods or goods which do not exist yet. They have become very popular in transportation economics (Hensher, 1997) and environmental economics (Adamowicz und Boxall, 2001) . Recently, there have been several applications of DCE in the health domain (for a survey see Ryan and Gerard, 2001 ). However, being hypothetical, DCE are subject to the criticism that they may fail to be related to (and ultimately predict) actual choices. Outside health, Louviere and Woodsworth (1983) have presented evidence suggesting that DCE can be used to explain modal choice in transportation, while Ghosh (1986) has found that they contribute to explaining the choice of a shopping mall. DCE with regard to health have so far been hardly related to actual choices (Ryan and Gerard, 2001 ).
The present contribution seeks to fill this gap, and in a context that may be deemed particularly difficult because one of the product attributes distinguished is risk reduction. It is well known that probabilities and changes in probabilities pose particular problems in surveys and experiments. The specific product in question is a hip protector that serves to all but eliminate the risk of fracture of the femur in aged persons. With an estimated mortality of up to 20 percent (Dubey et al., 1998) and treatment cost around US$ 30,000 per case and year (Barefield, 1996) , fractures of the femur are far from trivial. Therefore, their prevention is of some economic interest; on the other hand, hip protectors must be worn to be effective. This study relates willingness-to-pay (WTP) values estimated in a DCE (the stated choice) to the same respondents' later willingness to participate in a wearing trial of two months' duration (the actual choice). In this way, this study is likely to be the first in the health domain to confront results from a DCE with actual choices.
In section 2, the issues of reliability and validity as quality attributes of DCE are discussed in a review of the literature. In section 3, the methods used in the present DCE for establishing relevant product attributes and estimating marginal willingness-to-pay (MWTP) are described. Results with regard to convergent and criterion validity of DCEs are presented in section 4. Section 5 contains a discussion and conclusion.
Reliability and validity of DCE results
In the course of a DCE, respondents are confronted with a sequence of product varieties with changing product attributes. In each case, they are asked to indicate which of the presented varieties they prefer. In this way an indifference hyperplane in attribute space is approximated. Since one of the attributes is out-of-pocket price, the marginal rate of substitution between a particular attribute and price indicates the marginal willingness-to-pay (MWTP) for that attribute. The WTP for the product as a whole can be determined by integrating the MWTP values up to the corresponding attribute levels and aggregating (Johnson and Desvousges, 1997) .
Following Bateson et al. (1987) , "observed" (calculated) WTP, denoted by , can be split in DCE, they are even part of the specification, which is based on the random utility model.
Reliability
Reliability requires that measurements can be reproduced at least on average, which means that random errors are zero on expectation, ( ) 0
. There are several ways to check for reliability (see e.g. Litwin, 1995) : The test-retest method benefits from repeated measurement, while parallel testing involves the simultaneous use of two slightly different instruments.
Finally, in the alternate-form method the sample is split, with part of the observations reserved for reestimation using a variant of the measurement method.
DCE applied to health have but rarely been tested for reliability (Ryan and Gerard, 2001) . A likely reason is that additional observations come at a steep marginal cost, causing sample size to be rather small to begin with. Nevertheless, Farrar and Ryan (1999) using the alternate-form method found that the sequence of presentation of attributes did not change the setting of priorities in hospitals. Bryan et al. (2000) used the test-retest procedure by asking the same persons about their preferences for treatment of knee injuries within two weeks. The authors found a high degree of conformity between the two DCE. Telser and Zweifel (2002) using the same data as presented here performed an out-of-sample test in a DCE dealing with fractures of the femur. They concluded that DCE are an instrument of high reliability for measuring WTP for the reduction of a health risk.
Validity
The validity requirement is more stringent, requiring ( ) Hensher et al., 1999; Louviere et al., 1999) . However, juxtaposing CV and DCE results, Boxall et al. (1996) arrived at WTP estimates that were twenty times higher in the case of CV. At the same time, these authors were able to show that DCE results were in conformity with RP, i.e. with actual choice behavior. These findings are in line with other studies which cast doubt on the validity of the CV method (see, e.g., Hausman, 1993; Nocera et al., 2002) .
Outside health, the criterion validity of DCE has been tested on several occasions, causing Louviere (1988) to conclude that DCE constitute a valid instrument for explaining and predicting individual behavior on actual markets. More recently Johansson-Stenman and
Svedsäter (2003) observed that measured WTP for a public good did not differ much between a DCE with hypothetical payments and a subsequent DCE with real payments. However, in a control group that was only confronted with actual payments, WTP was substantially lower.
While this latter finding is not compatible with criterion validity, it may not carry over to private goods, to which a majority of health care services belong. In the context of health, the survey by Ryan and Gerard (2001) shows the validity of DCE to be still an open issue; specifically convergence and criterion validity seem not yet to have been tested.
Conclusion 1:
In contrast to environmental economics, discrete-choice experiments concerning health-related goods have been rarely checked for reliability and hardly for external validity, the latter involving convergent and criterion validity.
Methods
For the present study, aged persons were interviewed in a pretest in order to establish the relevant product attributes of a hip protector. Following standard DCE procedures, the product attributes of such a hip protector were preliminarily assumed to be protective effect, wearing, ease of handling, change of appearance, and out-of-pocket cost. In the pretest (N = 17), it turned out that the dimension 'appearance' was judged unimportant by a clear majority, justifying its exclusion from the main survey (see Telser and Zweifel, 2002 for details). The importance of the product attributes was again ascertained in the field survey. A majority of respondents judged all of the retained four attributes to be very important, notably the attribute 'out-of-pocket cost'. This may be surprising in health care systems with comprehensive health insurance coverage. However, in Switzerland insureds are subject to a degree of cost sharing especially in ambulatory care. This also makes a decision situation involving out-of-pocket payment less hypothetical for respondents.
The levels of the attributes were defined as follows (see Table 1 ). 'Protective effect' (PROT), symbolizing the risk reduction from an unknown individual level, takes on the values of 100, 75, and 50%. The choice of levels reflects the high effectiveness of existing variants of hip protectors (see e.g., Lauritzen et al., 1993; or Ekman et al., 1997) . 'Ease of handling ' (HAND) varies between 3 (very easy to put on) and 1. The same holds for 'wearing comfort' (COMF).
The 'out-of-pocket cost' (COST) ranges from CHF 0 to CHF 200 (US$ 133 at 1998 exchange rates), bracketing the price (CHF 80) typically paid by institutional purchasers. The reference scenario is the status quo (no purchase of hip protector). Since the first three attributes have 3 levels each, while COST has 4, the number of possible scenarios amounts to a total of 108 (= 3*3*3*4). Techniques have been developed to reduce the number of possible scenarios while still being able to infer utilities for all combinations of levels of the attributes (see Louviere et al., 2000) . Using the ORTHOPLAN procedure programmed in the software package SPSS, the design was reduced to 23 scenarios. These 23 variants were split into two subsets featuring a different sequence of presentation of the hip protectors to avoid boredom and bias on the part of respondents. With regard to each variant, respondents had to indicate whether or not they would buy the product.
The main survey consisted of 522 face-to-face interviews (of about 45 min length on average) with individuals aged 70 and older in the Summer of 1998. The sample is representative with regard to age and sex of the independently living Swiss subpopulation. At the end of the interview, participants in the survey were asked whether they were willing to take part in a wearing test of a specific hip protector (HIPS ® ) free of charge (COST = 0). In addition, they had to rate the product in terms of the three remaining attributes. The responses to the last part of the interview can be interpreted as an actual choice because participants were expected to document their trial in a diary during three months. This provides the basis for the test of criterion validity of DCE presented in section 4.2.
Results

Convergent validity: value of a statistical life
Willingness-to-pay for a marginal risk reduction can be extrapolated to obtain the value of a statistical life. Since CV as well as RP methods have been used for estimating this value, this
creates an opportunity for testing convergent validity. Focus will be on the RP alternative, which can be considered the 'gold standard' from the point of view of economics; in addition, it has been used more frequently than CV. RP estimates are most often based on wage differentials associated with differences in health risks between occupations (Viscusi, 1992).
There is an abundance of such estimates; therefore, the entries of Table 2 are derived from four surveys.
The results of the present study must be made comparable with those shown in Table 2 . First, calculated WTP is for a reduction of the risk of breaking the femur rather than the risk of death. In advance of the choice experiment it was ascertained that respondents did understand the risks associated with a fractured femur. Before making their hypothetical decisions in the DCE, respondents were informed about their risk of breaking the femur as well as the resulting risk of death. Mortality rates given fracture of the femur were used according to age class to estimate the implied relative reduction in mortality due to this particular cause (Hubacher and Ewert, 1997; Lippuner et al., 1997) . The associated marginal WTP values were then integrated for a protective effect of 100 percent which allowed the computation of the value of a statistical life. Second, the values cited in Table 2 are based on individuals around forty years of age. On theoretical grounds, Shepard and Zeckhauser (1982) predict that the relationship between the value of a statistical life and age is inversely U-shaped, with a maximum value around the age of forty. This prediction has been empirically confirmed by several authors (Carthy et al., 1999; Jones-Lee et al., 1985; Mount et al., 2000) . The estimate of the present study is made comparable with the international evidence as follows. Its mean value of life of US$ 1.9 mn, pertaining to individuals in the 70-75 age bracket is adjusted to an age of 40 years using the empirically found minimum and maximum values of the difference between ages 40 and 70 of the studies cited. The calculated minimum value amounts to US$ 2.4 mn, the maximum value to US$ 4.0 mn. An additional piece of evidence comes from divergent validity, which is the logical counterpart of convergent validity, requiring that values of a statistical life should differ if they are based on different concepts. Specifically, the human capital approach neglects aspects such as pain and suffering that enter the determination of WTP, a difference that may well be of particular importance among individuals of an advanced age. Therefore, the human capital approach should result in lower estimates of the value of a statistical life than the WTP approach adopted in this study. A study by Buzby et al. (1996) indeed finds a value of US$ 58,000 (1998 values) for 79-year old individuals (the average age in the present sample), which lies far below the US$ 670,000 calculated from the results of the present study. This makes estimation of a distribution function difficult.
Criterion validity: actual and stated choice
In this situation, prediction has to be replaced by postdiction. Thus, taking the split between participants and nonparticipants in the wearing trial as given, their mean WTP for HIPS ® can be calculated. This is done by integrating the MWTP values up to the relevant attribute levels and aggregating over attributes (Johnson and Desvousges, 1997) . With regard to attribute levels, note that the protective effect (PROT) of HIPS ® is set to 100 percent in view of biomechanical studies showing that wearing this hip protector completely eliminates the risk of fracture of the femur (Denoth, 1998) . Similarly, out-of-pocket cost (COST) is equal to zero because the protector was offered free of charge for the trial. A higher WTP among participants in the trial may therefore result from higher mean ratings of the two remaining attributes. Table 3 suggests that participants indeed rate both ease of handling and wearing comfort of the protector HIPS ® higher than do nonparticipants; however, the difference is not statistically significant. With regard to MWTP values for product attributes, the only improvement over the status quo is protective effect, whereas even the highest levels of ease of handling and wearing comfort still imply a deterioration compared to the status quo. Postdiction therefore amounts to saying that the marginal valuation of this one advantage relative to the two disadvantages should be higher in the participant group. In Table 4 , the MWTP for risk reduction (PROT) is slightly higher among participants in the trial. In addition, they exhibit significantly lower MWTP for the other two attributes than nonparticipants. This implies that participants are willing to sacrifice more ease of handling and wearing comfort for a given amount of risk reduction than nonparticipants, confirming expectations. Also shown in Table 4 are the estimated correction terms (equal to the ratio between the constant term and the coefficient of the cost attribute from the respective random effects probit specification). A negative correction term can be interpreted as the reservation price that has to be paid to compensate for the utility loss of having to wear a hip protector at all.
Such a reservation price mirrors an unfavorable basic attitude towards the product in question.
One would therefore expect the correction term (if negative) to be less marked among participants in the trial than nonparticipants. The entries of Table 4 Table 5 ) in that participants exhibit a mean value of stated WTP that is significantly positive whereas nonparticipants in the wearing trial display a significantly negative WTP on average. One might argue that a higher WTP among participants was to be expected in view of Table 4 ; however, the evidence presented in Table 5 goes beyond this.
Indeed, it is the postulated indirect utility function that yields the prediction that participants in the wearing trial derive more utility from nonprice product attributes than disutility from price. Since price is set to zero, their WTP should be positive and nonparticipants' WTP negative (reflecting their negative utility derived from nonprice attributes). Since they confirm the utility framework underlying DCE, the results presented in Table 5 thus constitute rather strong evidence in favor of DCE having criterion validity. 
Summary and conclusion
Measuring willingness-to-pay (WTP) for health-related goods is of considerable importance because the financiers of health -be they governments or health insurers -can use this information for matching the provision of health care more closely with the preferences of consumers, thus enhancing rationality of decision making in this domain (Zweifel, 2001 ).
However, this requires that measurements of WTP are valid in that they adequately reflect consumers' utility. A new and rapidly spreading method is the discrete-choice experiment (DCE), where respondents are confronted with product variants differing in attribute levels and asked to select the preferred one. Since one of these attributes is cost to the consumer, marginal WTP for an attribute can be derived from stated choices. By integrating marginal WTP to appropiate levels and aggregating across attributes, total WTP can be calculated as well. For all of its attractive features however, one important aspect of DCE has hardly been examined to date, viz. its external validity (Conclusion 1).
The present contribution purports to fill this gap by presenting evidence concerning convergent and criterion validity of a DCE involving a hip protector that could reduce the risk of fracture of the femur in an elderly Swiss population. Convergent validity requires the results of one method to come close to results based on an alternative that is considered valid.
In this study, the stated WTP for risk reduction was used to derive the value of a statistical life, which can be juxtaposed to values based on established alternatives, in particular revealed preference. While lower than US estimates, the DCE-based value of a statistical life is close to European counterparts, suggesting convergent validity. Conversely, a comparison with estimates derived from the human capital method yields a higher value for the DCE alternative, as was to be expected for theoretical reasons (Conclusion 2).
Criterion validity provides a more powerful test in that it requires stated choices to be related to actual choices. The distinguishing feature of the present study is that respondents not only made hypothetical choices but also indicated their willingness to participate in a wearing trial, which amounts to an actual choice. Ideally, individual WTP values based on DCE should serve as predictors of actual choice. However, individual WTP values could not be calculated in this sample due to its high degree of homogeneity. This still leaves scope for postdiction in that participants should exhibit stated marginal and total WTP values that differ from those of nonparticipants. Indeed, among participants the attribute 'risk reduction' turns out to be more valuable in comparison to ease of handling and wearing comfort than among nonparticipants.
As to stated total WTP, it should have the price of the product as an upper bound among nonparticipants and as a lower bound among participants in the wearing trial. Since price is zero (the trial being offered free of charge), nonparticipants are expected to exhibit negative and participants positive stated WTP. This expectation is confirmed as well, providing rather strong evidence in favor of DCE having criterion validity (Conclusion 3).
In all, the tests performed suggest that DCE may have a high degree of external validity even in difficult applications. For in this study, respondents were 79 years old on average, and they were asked to value risk reductions, i.e. changes in probability, a concept many people have difficulty with. On the other hand, at least two qualifications are in order. First, it was not possible to use stated WTP values as predictors of individual choices, which often constitutes the ultimate objective of such an exercise (Hall et al., 2002) . Second, in Swiss health care insureds are still used to a degree of cost sharing, which serves to make a decision situation involving out-of-pocket cost less hypothetical than in countries with comprehensive coverage or a national health service. Therefore, the final verdict about the merits of DCE is not out yet when it comes to truly public goods in health care.
